Creating AI to simulate biology and improve the lives of patients
Science First
Unlearn was founded by scientists, who wanted to find a new, evidence-based approach. We operate based on proprietary approaches to machine learning principles and regulatory guidances.
A Culture of Precision
Statistical rigor and clinical excellence drive us. We are impacting patient lives, and we hold ourselves to the highest standards.
Trusted Innovator
We are working diligently towards validated innovation. We ensure our products address our customers' exact needs while mitigating risk.
Culture and team
Unlearn was started to solve hard problems. We foster an environment and culture that empowers everyone to do their best work, so we can find solutions together.
A fascinating approach to the problem of how to make clinical trials more efficient, and understand more about what may be possible with more and better patient data.
Unlearn.AI nabs $12M to build “Digital Twins” to speed up and improve clinical trials
April 20, 2020
“Unlearn’s pioneering use of Digital Twins will limit the number of patients that need to go on placebo while also reducing overall trial enrollment time."
Will digital clones transform how pharmas run clinical trials? This S.F. startup is counting on it.
May 4, 2020
The San Francisco-based company creates digital replicas of participants in clinical drug trials using artificial intelligence. The result, says Charles Fisher...
